Integra Lifesciences (IART) versus Coherent (COHR) Head to Head Contrast

Integra Lifesciences (NASDAQ: IART) and Coherent (NASDAQ:COHR) are both mid-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their profitability, dividends, institutional ownership, earnings, analyst recommendations, valuation and risk.

Volatility and Risk

Integra Lifesciences has a beta of 0.65, indicating that its share price is 35% less volatile than the S&P 500. Comparatively, Coherent has a beta of 0.97, indicating that its share price is 3% less volatile than the S&P 500.

Earnings & Valuation

This table compares Integra Lifesciences and Coherent’s revenue, earnings per share and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Integra Lifesciences $1.19 billion 4.86 $64.74 million $1.94 33.89
Coherent $1.72 billion 2.23 $207.12 million $12.57 12.32

Coherent has higher revenue and earnings than Integra Lifesciences. Coherent is trading at a lower price-to-earnings ratio than Integra Lifesciences, indicating that it is currently the more affordable of the two stocks.


This table compares Integra Lifesciences and Coherent’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Integra Lifesciences 5.39% 17.90% 6.14%
Coherent 12.65% 29.28% 14.97%

Insider & Institutional Ownership

79.5% of Integra Lifesciences shares are held by institutional investors. Comparatively, 98.4% of Coherent shares are held by institutional investors. 5.1% of Integra Lifesciences shares are held by insiders. Comparatively, 1.4% of Coherent shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Analyst Recommendations

This is a breakdown of current ratings and price targets for Integra Lifesciences and Coherent, as reported by MarketBeat.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Integra Lifesciences 0 10 4 0 2.29
Coherent 0 0 9 0 3.00

Integra Lifesciences currently has a consensus price target of $60.00, suggesting a potential downside of 8.75%. Coherent has a consensus price target of $268.38, suggesting a potential upside of 73.23%. Given Coherent’s stronger consensus rating and higher possible upside, analysts plainly believe Coherent is more favorable than Integra Lifesciences.


Coherent beats Integra Lifesciences on 11 of the 14 factors compared between the two stocks.

About Integra Lifesciences

Integra LifeSciences Holdings Corporation develops, manufactures, and markets surgical implants and medical instruments for use in neurosurgery, extremity reconstruction, orthopedics, and general surgery. The company operates in two segments, Codman Specialty Surgical, and Orthopedics and Tissue Technologies. It offers neurosurgery and neuro critical care products, including tissue ablation equipment, dural repair products, cerebral spinal fluid management devices, intracranial monitoring equipment, and cranial stabilization equipment. The company also sells approximately 60,000 instrument patterns, and surgical and lighting products to hospitals and surgery centers, as well as dental, podiatry, and veterinary offices. In addition, it provides regenerative technology products for the treatment of acute and chronic wounds; and surgical tissue repair products for hernia repair, peripheral nerve repair and protection, and tendon repair. Further, the company sells hardware products, such as bone and joint fixation, and joint replacement devices; implants; and instruments, which provide for the orthopedic reconstruction of bone in the hand, wrist, elbow, and shoulder, as well as the foot, ankle, and leg below the knee in the extremity bone and joint reconstruction procedures. Integra LifeSciences Holdings Corporation offers its products directly through various sales forces and other distribution channels in the United States, Europe, and internationally. The company was founded in 1989 and is headquartered in Plainsboro, New Jersey.

About Coherent

Coherent, Inc. provides lasers and laser-based technology in a range of scientific, commercial, and industrial applications worldwide. It operates through two segments, Specialty Lasers and Systems, and Commercial Lasers and Components. The company designs, manufactures, services, and markets lasers, laser tools, precision optics, and related accessories. Its products are used in markets, such as microelectronics, materials processing, original equipment manufacturer components and instrumentation, and scientific research and government programs. The company markets its products through a direct sales force in the United States, as well as through direct sales personnel and independent representatives internationally. Coherent Inc. was founded in 1966 and is headquartered in Santa Clara, California.

Receive News & Ratings for Integra Lifesciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Integra Lifesciences and related companies with's FREE daily email newsletter.

Leave a Reply